Sculptor Capital LP - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 39 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$9,323
+16.5%
150,0000.0%0.00%
Q3 2022$8,000
-20.0%
150,0000.0%0.00%
Q2 2022$10,000
-71.4%
150,0000.0%0.00%
Q1 2022$35,000
-62.8%
150,0000.0%0.00%
-100.0%
Q4 2021$94,000
-3.1%
150,0000.0%0.00%0.0%
Q3 2021$97,000
-25.4%
150,0000.0%0.00%0.0%
Q2 2021$130,000
+51.2%
150,0000.0%0.00%0.0%
Q1 2021$86,000150,0000.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2021
NameSharesValueWeighting ↓
Kingstown Capital 300,000$72,0000.11%
Telemetry Investments, L.L.C. 153,694$36,0000.06%
Kamunting Street Capital Management, L.P. 158,962$38,0000.05%
Radcliffe Capital Management, L.P. 202,950$2,001,0000.04%
Q Global Advisors, LLC 300,000$72,0000.04%
Integrity Capital Management (HK) Ltd 33,267$8,0000.04%
Corbin Capital Partners, L.P. 464,062$111,0000.02%
HGC Investment Management Inc. 1,215,782$292,0000.02%
Segantii Capital Management Ltd 50,000$493,0000.01%
Sage Rock Capital Management LP 286,900$69,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders